Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of duloxetine and pregabalin on invalidation in fibromyalgia
IRCT20181113041646N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine and pregabalin in fibromyalgia (FM), sponsored by Guilan University of Medical Sciences. Primary endpoint: Change in invalidation in fibromyalgia. Started Nov 2019; status: completed.
02
Drugs
duloxetinepregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on IRCT20181113041646N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181113041646N1.